異體造血幹細胞移植之前置化療強度對於骨髓纖維化病人之影響：系統性回顧、統合分析與臨床試驗計畫書

Background Despite the advent of novel therapies, including JAK inhibitors and immunomodulatory agents, allogeneic hematopoietic stem cell transplant (Allo-HSCT) is viewed as the ultimate cure for myelofibrosis (MF). However, treatment toxicities of conditioning regimens are major concerns. Meanwhil... View More